Author:
Relimpio F.,Guerrero R.,Martínez-Brocca M. A.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference16 articles.
1. Avignon A, Radauceanu A, Monnier L (1997) Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in Type 2 diabetes. Diabetes Care 20:1822–1826
2. Bastyr EJ, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE, for the IOEZ Study Group (2000) Therapy focused on lowering glucose, not fasting glucose, may be superior for lowering HbA1c. Diabetes Care 23:1236–1241
3. Bonora E, Calcaterra F, Lombardi S, Bonfante N, Formentini G, Bonadonna RC, Muggeo M (2001) Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care 24:2023–2029
4. Holman RR, Turner RC (1988) Optimizing blood glucose control in Type 2 diabetes: an approach based on fasting blood glucose measurements. Diabetologia 5:582–588
5. Trovati M, Burzacca S, Mularoni E, Massuco P, Cavalot F, Mattiello L, Anfossi G (1992) A comparison of the predictive power for overall blood glucose control of a ‘good’ fasting level in Type 2 diabetic patients on diet alone or with oral agents. Diabetologia 9:134–137
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. GLP-1-Rezeptoragonisten in der Therapie des Typ-2-Diabetes;Diabetologie und Stoffwechsel;2015-07-10
2. Current literature in diabetes;Diabetes/Metabolism Research and Reviews;2008